ChartPilotPre-clinic chart preparation
Synthetic data — not for clinical use
← Back to patient list

Priya Nair

CompletedDemo data (offline)

MRN-51907

Stage: DONE

Findings

No high-priority findings identified

Automated review of this chart did not identify findings that meet the threshold for flagging. This does not replace clinician judgment during the visit.

Patient history

  1. 2024-02-01
    Annual wellness visit
    Routine annual exam, no acute concerns raised.
  2. 2024-02-01
    Lipid panel within reference range
    LDL 101 mg/dL, HDL 55 mg/dL, triglycerides 118 mg/dL.
  3. 2024-05-14
    Levothyroxine 50 mcg daily continued
    Refill of stable, long-standing thyroid replacement dose.
  4. 2024-08-06
    TSH within reference range
    TSH 2.3 mIU/L, consistent with adequate thyroid replacement.
  5. 2025-02-03
    Annual wellness visit
    Routine annual exam, no acute concerns raised.
  6. 2025-02-03
    Lipid panel within reference range
    LDL 99 mg/dL, HDL 57 mg/dL, triglycerides 112 mg/dL.
  7. 2025-05-12
    Levothyroxine 50 mcg daily continued
    Refill of stable, long-standing thyroid replacement dose.
  8. 2025-08-08
    TSH within reference range
    TSH 2.2 mIU/L, consistent with adequate thyroid replacement.
  9. 2026-02-04
    Annual wellness visit
    Routine annual exam, no acute concerns raised.
  10. 2026-02-04
    Lipid panel within reference range
    LDL 96 mg/dL, HDL 58 mg/dL, triglycerides 110 mg/dL.
  11. 2026-05-11
    Levothyroxine 50 mcg daily continued
    Refill of stable, long-standing thyroid replacement dose.
  12. 2026-08-09
    TSH within reference range
    TSH 2.1 mIU/L, consistent with adequate thyroid replacement.

Recent labs

  • TSH
    2.1 mIU/Las of 2026-08-09
  • LDL Cholesterol
    96 mg/dLas of 2026-02-04
  • Hemoglobin A1c
    5.3 %as of 2026-02-04